ArticleMedical oncology (Northwood, London, England)2021

Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal's letter to the editor.

L Triggiani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.